Mode
Text Size
Log in / Sign up
N/A N=14 Randomized Prevention

Impact Loading Effect on Bone Biomarkers in Female Runners

Relative Energy Deficiency in Sport

Enrolled (actual)
14
Serious AEs
0.0%
Results posted
Aug 2025
Primary outcome: Primary: Change in Bone Remodeling Biomarker - N-terminal Propeptide of Type 1 Procollagen — -3.1; 1.1 ng/mL — p=0.246

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Impact Load Exercises (Behavioral); No Impact Load Exercises (Behavioral)
Age
Adult · 18+ yrs
Sex
Female
Sponsor
Virginia Polytechnic Institute and State University
Primary completion
Jan 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Bone Remodeling Biomarker - N-terminal Propeptide of Type 1 Procollagen
-3.1; 1.1 0.246
PRIMARY
Change in Bone Remodeling Biomarker - C-terminal Telopeptide of Type 1 Collagen (CTX)
0.04; 0.04 0.714
PRIMARY
Change in Blood Metabolic Marker - Parathyroid Hormone
3.3; -1.0 0.309
PRIMARY
Change in Blood Metabolic Marker - Insulin-like Growth Factor-1
-11.4; -8.0 0.308
SECONDARY
Change in Ferritin
4.1; 11.4 0.207

Summary

This study is a randomized, cross-over intervention study that will evaluate the effect of brief, high-impact loading exercises on biomarkers of bone metabolism in energy-restricted female runners. Volunteers will complete two 5-day experimental conditions in a randomized order separated by one menstrual cycle (approximately 3 weeks). Experimental conditions will include a dietary intervention of energy intake equal to 30 kcal/kg of fat-free mass/d using controlled diets and an exercise intervention of daily treadmill running with or without an additional 50 impact loading exercises.

Eligibility Criteria

Inclusion Criteria

  • Females runners with regular menstrual cycles, not using contraceptives
  • Body Mass Index between 18.5-30.0 kg/m2
  • Weight stable (+/- 2 kg) for 6 months
  • VO2max of ≥35 ml/kg/min
  • Willing to consume provided meals and snacks

Exclusion Criteria

  • Low Energy Availability in Females Questionnaire (LEAF-Q) score ≥8
  • Menstrual disturbances measured by progesterone and self-report
  • Using contraceptives (oral contraceptives, injections, intrauterine device, etc.)
  • Low Bone Mineral Density (z-score < -1)
  • Routine engagement in mechanical loading exercises
  • History of fracture in the previous 6 months
  • Recent recovery (within the last 12 months) or still in recovery after eating disorder diagnosis
  • Medication use that could affect bone metabolism (e.g., corticosteroids, anticonvulsants, heparin, gonadotropin-releasing hormone agonists)
  • Pregnancy or lactation
  • Abnormal thyroid-stimulating hormone levels
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05341700). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search